Sterile injectable pharmaceutical manufacturing operates within tightly controlled environments where contamination control is critical. Cleanrooms are designed to minimise risk, as even submicron particles can compromise product integrity and patient safety.
While significant investment is often directed towards sophisticated facility design and high-end processing machinery, the most volatile element within any cleanroom remains the human operator.
It is well documented that a substantial proportion of cleanroom excursions originate from contaminants of human origin. To mitigate this risk, gowning serves as the primary and most critical barrier between the operator and the sterile process.
However, if not correctly designed, monitored, and managed, cleanroom garments themselves can become a significant, yet frequently overlooked, source of particle shedding.
When the Barrier Becomes the Source
Cleanroom garments are, in essence, engineered filtration systems designed to contain human-sourced contamination such as hair, skin cells, and associated microorganisms.
Research suggests that the cleanliness and performance of these garments are not static attributes. Instead, they are directly influenced by the fabric’s inherent tendency to degrade over time with use, leading to the shedding of particles and fibres, as well as, to a significant extent, by the quality of their design and stitching.
This presents a complex challenge for Quality Assurance and Cleanroom Operations professionals. Under certain conditions, the very system implemented to prevent contamination can become the primary vector for it.
Fabric Degradation Through Repeated Use and Sterilisation
Cleanroom garments are subjected to repeated mechanical, chemical, and thermal stresses. Aggressive laundering processes and sterilisation methods, such as autoclaving or gamma irradiation, progressively degrade fabric integrity.
Research indicates that reusable cleanroom garments must be validated to ensure they maintain protective performance throughout their entire service life. As garments age, fibre strength diminishes.
Measurable reductions in tensile strength or changes in fabric mass often serve as early indicators of material degradation, well before visible damage appears. At this stage, microscopic fibres may already be released into the controlled environment, directly increasing non-viable particle counts.
Electrostatic Behaviour and Particle Attraction
This challenge is further compounded by the diminishing electrostatic discharge (ESD) capabilities of garment fabrics during use. Traditional cleanroom gowns are typically composed of 98–99% polyester, with the remaining fraction formed by a carbon filament grid or stripe. Carbon filaments are inherently soft and degrade under repeated friction during use, washing, and drying, creating discontinuities in the grid that progressively diminish ESD performance.
Electrostatically charged garments actively attract non-viable particles, increasing the overall particle burden in critical areas. Rather than functioning solely as a passive barrier, the garment becomes a collection surface for contaminants, which are subsequently released during operator movement.
This effect is further amplified by the bellows effect, whereby air is forced through garment openings during routine motion, dispersing accumulated particles into the cleanroom.
It is also important to note that anti-static footwear is essential for effective ESD control. Garments incorporating fabric soles in booties tend to degrade carbon properties more rapidly due to friction during walking, thereby compromising the earthing effectiveness of the entire gowning system.
Arbitrary Replacement Cycles and Hidden Risk
Many pharmaceutical facilities continue to rely on arbitrary gown replacement schedules. In the absence of performance-based data, garments are often retained in service long after their filtration efficiency has declined.
Research suggests that appropriate garment selection and effective lifecycle management can significantly influence cleanroom performance, in some cases even supporting lower air change rates when contamination is effectively controlled at source.
When garments remain in circulation beyond validated performance thresholds, they represent a continuous and invisible threat to the contamination control strategy required under revised regulatory frameworks such as EU GMP Annex 1.
Regulatory Expectations Under EU GMP Annex 1
The revised EU GMP Annex 1 places strong emphasis on a holistic, documented contamination control strategy, with gowning identified as a foundational element.
Regulatory authorities increasingly expect manufacturers to provide data-driven justification for gowning protocols, including scientifically defined end-of-life criteria for sterile apparel.
For many facilities, the challenge lies in the absence of in-house capability to assess fabric degradation at a microscopic or structural level. Visual inspection alone is insufficient, as losses in filtration efficiency, tensile strength, or electrostatic performance typically occur well before physical defects become visible.
This gap frequently results in either premature garment disposal or the continued use of garments that have already become a particle-shedding risk.
The Solution: Validated Lifecycle and Strategic Design
To reduce particle shedding, pharmaceutical facilities must implement a validated garment lifecycle, ensuring garments are retired only when performance genuinely declines, neither prematurely nor after they pose a contamination risk.
Strategic garment design represents the first control point. High-performance cleanroom apparel, such as the solutions developed by Alsico Asia Tech and Union Micronclean Company, Thailand, utilises fabrics with high filtration efficiency for 0.3- and 0.5-micron particles, often achieving performance in the high 90th percentile.
Construction features such as heat-sealed or fused edges, along with lapped seams and double-needle stitching, prevent fraying and fibre release.
Anti-static properties further reduce contamination risk by limiting perspiration, operator discomfort, and unhygienic behaviour. Combined with controlled air and water vapour permeability, these garments maintain operator comfort while minimising the bellows effect during movement.
Implementing a Lifecycle Validation Programme
Transitioning to lifecycle validation follows a structured five-step process:
- Requirement review: Align garment types with cleanroom classifications.
- Protocol definition: Establish test methods, frequencies, and acceptance criteria.
- Specimen collection: Evaluate garments when new and after defined autoclave cycles (20, 40, 60, and 80).
- Standardised testing: Conduct weight testing (EN 12127-A), tensile strength testing (ISO 13934-1), filtration efficiency testing (Unitika method), and body box testing (IEST-RP-CC003.4), among others.
- Data analysis: Use results to define a scientifically justified maximum garment lifecycle.
This data-driven approach enhances contamination control, strengthens regulatory compliance, and optimises cost by preventing premature garment disposal.
Summing Up
Particle shedding from cleanroom garments is a persistent but controllable risk. Through advanced garment design based on IEST standards and validated lifecycle management, pharmaceutical manufacturers can significantly reduce both viable and non-viable contamination while reinforcing regulatory compliance.
Moving beyond arbitrary gowning limits to a data-driven, validated approach safeguards product integrity, patient safety and organisational reputation.
Is your gowning protocol supported by scientific evidence?
Contact Team Grover Holdings at vivek@groverholdings.com or call +91 98211 11623 to understand how validated cleanroom garment solutions can strengthen your Contamination Control Strategy.